Karmele Olaciregui Dague

Dr. Karmele Olaciregui Dague

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2022 in Epilepsia
Verified
Journal Article
Open access
TBTobias Baumgartner
Tobias Baumgartner
JPJulika Pitsch
Julika Pitsch
KDKarmele Olaciregui Dague
Karmele Olaciregui Dague
CHChristian Hoppe
Christian Hoppe
ARAttila Racz
Attila Racz
RSRainer Surges
Rainer Surges
Patients with anti‐leucine‐rich glioma‐inactivated 1 protein (LGI1) or anti‐contactin‐associated protein 2 (CASPR2) antibody encephalitis typically present with frequent epileptic seizures. The seizures generally respond well to immunosuppressive therapy, and the long‐term seizure outcome seems to be favorable. Consequentially, diagnosing acute symptomatic seizures secondary to autoimmune encephalitis instead of autoimmune epilepsy was proposed. However, published data on long‐term seizure outcomes in CASPR2 and LGI1 antibody encephalitis are mostly based on patient reports, and seizure underreporting is a recognized issue. Clinical records from our tertiary epilepsy center were screened retrospectively for patients with LGI1 and CASPR2 antibody encephalitis who reported seizure freedom for at least 3 months and received video‐electroencephalography (EEG) for >24 h at follow‐up visits. Twenty (LGI1, n = 15; CASPR2, n = 5) of 32 patients with LGI1 (n = 24) and CASPR2 (n = 8) antibody encephalitis fulfilled these criteria. We recorded focal aware and impaired awareness seizures in four of these patients (20%) with reported seizure‐free intervals ranging from 3 to 27 months. Our results question the favorable seizure outcome in patients with CASPR2 and LGI1 antibody encephalitis and suggest that the proportion of patients who have persistent seizures may be greater. Our findings underline the importance of prolonged video‐EEG telemetry in this population.

9 March 2023 in Frontiers in Neurology
Verified
Journal Article
Open access
KDKarmele Olaciregui Dague
Karmele Olaciregui Dague
JWJuri-Alexander Witt
Juri-Alexander Witt
RWRandi von Wrede
Randi von Wrede
CHChristoph Helmstaedter
Christoph Helmstaedter
RSRainer Surges
Rainer Surges
Objective: Evaluation of the antiseizure efficacy, side effects and neuropsychological effects of Deep brain stimulation (DBS) of the anterior nucleus of the thalamus (ANT). ANT-DBS is a treatment option for patients with difficult-to-treat epilepsy. Though several works outline the cognitive and/or mood effects of ANT-DBS for the treatment of epilepsy, data on the intersection between antiseizure efficacy, cognitive and undesired effects are scarce.Methods: We retrospectively analyzed the data of our cohort of 13 patients. Post-implantation seizure frequencies were measured at 6 months, 12 months and last follow-up, as well as averaged throughout follow-up. These values were then compared with mean seizure frequencies in the 6 months before implantation. To address acute cognitive effects of DBS a baseline assessment was performed after implantation and before stimulation, and a follow-up assessment was conducted under DBS. The long-term effects of DBS on cognition were assessed by comparing the preoperative neuropsychological profile with a long-term follow-up under DBS.Results: In the entire cohort, 54.5% of patients were responders, with an average seizure reduction of 73.6%. One of these patients achieved temporary seizure freedom and near-total seizure reduction during the entire follow-up. Seizure reduction of <50% was achieved in 3 patients. Non-responders suffered an average seizure increase of 27.3%. Eight of twenty-two active electrodes (36,4%) were off-target. Two of our patients had both electrodes implanted off-target. When removing these two patients from the analysis and averaging seizure frequency during the entire follow-up period, four patients (44.4%) were responders and three experienced a seizure reduction of <50%. Intolerable side effects arose in 5 patients, mostly psychiatric. Regarding acute cognitive effects of DBS, only one patient showed a significant decline in executive functions. Long-term neuropsychological effects included significant intraindividual changes in verbal learning and memory. Figural memory, attention and executive functions, confrontative naming and mental rotation were mostly unchanged, and improved in few cases.Significance: In our cohort, more than half of patients were responders. Psychiatric side effects seem to have been more prevalent compared to other published cohorts. This may be partially explained by a relatively high occurrence of off-target electrodes.

4 April 2020 in Internal and Emergency Medicine
Verified
Journal Article
Closed access
PDF file
LVLuigi Villa
Luigi Villa
OMOliver Matz
Oliver Matz
KDKarmele Olaciregui Dague
Karmele Olaciregui Dague
DKDavid Kluwig
David Kluwig
RRRolf Rossaint
Rolf Rossaint
JBJörg Christian Brokmann
Jörg Christian Brokmann

18 December 2015 in SpringerPlus
Verified
Journal Article
Open access
PDF file
FCFelipe Counago
Felipe Counago
ECElia del Cerro
Elia del Cerro
AGAna Aurora Diaz Gavela
Ana Aurora Diaz Gavela
FMFrancisco José Marcos
Francisco José Marcos
MRManuel Recio
Manuel Recio
LCLaura Cerezo
Laura Cerezo
To assess and validate the incorporation of the multiparametric magnetic resonance imaging (mpMRI) tumour category (mT-category) to the conventional clinical tumour category (cT-category), in order to guide the radiotherapy (RT) treatment decisions in prostate cancer. In addition, to identify the clinical factors associated to the technique reliability. mpMRI was performed in 274 prostate cancer patients in order to refine the treatment decisions according to PSA, Gleason Score (GS) and cT-category. Comparisons between the cT and mT-category were performed, as well as the impact on the RT treatment [target volume, doses and hormonal therapy (HT)] independently if it was finally performed. Changes in HT indication for intermediate risk were also analyzed. mpMRI validation was performed with pathological staging (n = 90 patients finally decided to join surgery). The mpMRI upstaging range was 86–94 % for any PSA value or GS. Following mpMRI, 32.8 % of the patients (90/274) were assigned to a different risk group. Compared to cT-category, mpMRI identified more intermediate-risk (46.4 vs. 59.5 %) and high-risk (19.0 vs. 28.8 %) prostate cancer patients. This resulted in a higher indication (p < 0.05) of seminal vesicle irradiation (63.5 vs. 70.0 %), inclusion of any extracapsular disease (T3–T4) within the target volume (1.8 vs. 18.2 %), higher doses (65.3 vs. 88.3 %) and HT associated to RT (45.6 vs. 62.4 %). Global accuracy for mpMRI was higher compared to DRE/TRUS (8.9 vs. 71.1 %, p < 0.05). mpMRI reliability was independent of PSA or GS. mpMRI tumor staging significantly modified the RT treatment decisions in all prostate cancer risk groups.

1 May 2019 in Epilepsy & Behavior
Verified
Journal Article
Closed access
YMYasser Mahdavi
Yasser Mahdavi
RSRainer Surges
Rainer Surges
ONOmid Nikoubashman
Omid Nikoubashman
KDKarmele Olaciregui Dague
Karmele Olaciregui Dague
JBJörg C. Brokmann
Jörg C. Brokmann
OMOliver Matz
Oliver Matz

5 April 2021 in Palliative and Supportive Care
Verified
Journal Article
Open access
PDF file
BMBeatriz Moreno-Milan
Beatriz Moreno-Milan
BBBill Breitbart
Bill Breitbart
BHBenjamín Herreros
Benjamín Herreros
KDKarmele Olaciregui Dague
Karmele Olaciregui Dague
MPMaría Cristina Coca Pereira
María Cristina Coca Pereira
Background: Traditionally, the psychological well-being of healthcare workers has been taken for granted — it has even been considered a part of the requirements that were demanded of them. When these professionals have experienced suffering and psychological depletion, they have been held accountable for this suffering, adopting an individualistic and reductionist viewpoint focused only on the professional. This approach has become obsolete due to its proven ineffectiveness, especially from an ethics of responsibility and organization viewpoint.Context: The psychological well-being of the healthcare worker (and its opposites: suffering, exhaustion, and disenchantment) is advantageous to the professional's commitment to the institution, to their work performance, and to their personal life.Objective: The objective of this paper is to reflect on the psychological suffering of the palliative care professional.Method: We will reflect on the three levels of responsibility that influence such suffering (micro-meso-macro-ethical; worker-environment-institution).Results: We will propose a global strategy for the care of psychological well-being supported by scientific evidence and key references.Significance of results: We conclude with some contributions on what we have learned and still have to learn on this topic.